−0.15 PLN
28.94 M PLN
299.00 K PLN
1.99 M
About PHARMENA
Sector
Industry
CEO
Konrad Palka
Website
Headquarters
Lodz
Founded
2002
ISIN
PLPHRMN00011
FIGI
BBG000BLWRR6
PHARMENA SA engages in developing and marketing products based on a patented, physiological, and natural active substance 1-MNA. It focuses on clinical research on innovative anti-atherosclerotic medicinal product, production of innovative dermatological products, and introduction of innovative dietary supplement used for special nutritional needs in the prevention of atherosclerosis. It distributes its products under the Menavitim, Dermena, Allerco, and Thermi brands. The company was founded by Jerzy Gebicki on November 12, 2002 and is headquartered in Lodz, Poland.
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
The current price of PHR is 3.83 PLN — it has decreased by −0.26% in the past 24 hours. Watch PHARMENA stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on GPW exchange PHARMENA stocks are traded under the ticker PHR.
PHR stock hasn't changed in a week, the month change is a −16.52% fall, over the last year PHARMENA has showed a −39.59% decrease.
PHR stock is 6.34% volatile and has beta coefficient of 0.21. Track PHARMENA stock price on the chart and check out the list of the most volatile stocks — is PHARMENA there?
Today PHARMENA has the market capitalization of 42.88 M, it has decreased by −10.90% over the last week.
Yes, you can track PHARMENA financials in yearly and quarterly reports right on TradingView.
PHR net income for the last quarter is −475.00 K PLN, while the quarter before that showed −904.00 K PLN of net income which accounts for 47.46% change. Track more PHARMENA financial stats to get the full picture.
Yes, PHR dividends are paid annually. The last dividend per share was 0.85 PLN. As of today, Dividend Yield (TTM)% is 22.08%. Tracking PHARMENA dividends might help you take more informed decisions.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. PHARMENA EBITDA is −3.05 M PLN, and current EBITDA margin is −1.24 K%. See more stats in PHARMENA financial statements.
Like other stocks, PHR shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade PHARMENA stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So PHARMENA technincal analysis shows the sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating PHARMENA stock shows the strong sell signal. See more of PHARMENA technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.